Clinical Trial Update: Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions [Phase 1]

View source ↗

Summary

A completed Phase 1 study assessed the bioavailability of candesartan cilexetil 8 mg tablet under fasting conditions in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED